These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Tumor size and survival in lung cancer, stage IA].
    Author: Lyons G, Quadrelli S, Chimondegy D, Iotti A, Silva C.
    Journal: Medicina (B Aires); 2008; 68(1):23-30. PubMed ID: 18416316.
    Abstract:
    TNM staging is an important long-term predictor for survival of lung cancer patients. Some studies have shown, however, that tumor size may have intrinsic prognostic value independent of TNM stage. The relationship between tumor size and survival is particularly unclear in T1 tumors. The objective of this study was to assess the prognostic value of tumor size in surgically resected stage I of non-small cell lung cancer (NSCLC). Clinical records of 79 patients with stage IA NSCLC were reviewed. In 34.4% of patients (n = 28) size was < or = 1.5 cm. Surgical mortality was 1.3%. Disease recurrence was noted in 19%. Patients with tumors < or = 15 mm had a significantly higher 5-year survival (95% CI:0.05 vs. 77% CI: 0.07 in > 15mm group). Disease-free survival was 95% for tumors less than 15 mm vs. 72% in larger tumors. Using Cox Multivariate analysis, the most determinant factor for higher risk of mortality was size > 15 mm (relative risk 25.9, IC: 2.3-292, p = 0.004). The independent influence of tumor size in stage IA NSCLC may have practical implications with regards to proposals for screening asymptomatic individuals at high risk for lung cancer.
    [Abstract] [Full Text] [Related] [New Search]